Biomedical Advanced Research and Development Authority (BARDA)
330 C Street, SW
Room G640
Washington
D.C.
20201
United States
Tel: 202-260-1200
Fax: 202-205-4520
238 articles about Biomedical Advanced Research and Development Authority (BARDA)
-
Emergent BioSolutions Awarded $19.7 Million Biomedical Advanced Research and Development Authority (BARDA) Contract To Develop And Manufacture Ebola Monoclonal Antibodies
7/20/2015
-
Nanotherapeutics Awarded Biomedical Advanced Research and Development Authority (BARDA) Fill-Finish Manufacturing Network Task Orders To Develop Two FDA Drug Shortage Products
7/10/2015
-
Infectious Disease Research Institute (IDRI) Announces $4M Biomedical Advanced Research and Development Authority (BARDA) Cooperative Agreement To Establish Adjuvant Hub
2/19/2015
-
VaxInnate Corporation Receives Extension Of Contract From Biomedical Advanced Research and Development Authority (BARDA) For Development Of Seasonal And Pandemic Influenza Vaccines
2/17/2015
-
Cytori Therapeutics, Inc. And Biomedical Advanced Research and Development Authority (BARDA) Amend Contract Option To Accelerate The Advancement Of A Thermal Burn Injury Countermeasure
12/19/2014
-
Cempra To Receive Biomedical Advanced Research and Development Authority (BARDA) Funding For 1b And Start-Up Of Phase 2/3 Solithromycin Pediatric Studies
11/19/2014
-
Atox Bio Awarded Contract Worth Up To $24 Million For The Development Of AB103 By The Biomedical Advanced Research and Development Authority (BARDA)
9/29/2014
-
Novavax, Inc. Announces Biomedical Advanced Research and Development Authority (BARDA) Exercise Of Contract Option
9/23/2014
-
Chimerix, Inc. And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox
9/2/2014
-
Biomedical Advanced Research and Development Authority (BARDA) Extends Contract With Cytori Therapeutics, Inc. For Burn Treatment, Deal Is Worth Up To $20.4 Million
8/19/2014
-
Cytori Therapeutics, Inc. Receives Notice Of Intent To Exercise First Contract Option From Biomedical Advanced Research and Development Authority (BARDA)
7/7/2014
-
Biota Pharmaceuticals, Inc. Provides Update On Biomedical Advanced Research and Development Authority (BARDA) Contract For Laninamivir Octanoate
5/8/2014
-
Novavax, Inc. Announces Extension Of Contract For Advanced Development Of Recombinant Influenza Products And Pandemic Preparedness With Department of Health and Human Services-Biomedical Advanced Research and Development Authority (BARDA)
2/28/2014
-
The Medicines Company Wins Biomedical Advanced Research and Development Authority (BARDA) Antibiotic Contract Worth Up To $90 Million
2/5/2014
-
Theraclone Sciences, Inc. Gets Bad News From Biomedical Advanced Research and Development Authority (BARDA) Regarding Pandemic Flu Drug
11/27/2013
-
Argentum Medical LLC Awarded Biomedical Advanced Research and Development Authority (BARDA) Contract Valued Up to $16.5 Million
10/22/2013
-
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
10/1/2013
-
Novavax, Inc. to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With Biomedical Advanced Research and Development Authority (BARDA)
9/24/2013
-
GlaxoSmithKline Inks $196 Million Biomedical Advanced Research and Development Authority (BARDA) U.S. Anthrax Treatment Deal
9/20/2013
-
Soligenix Awarded Biomedical Advanced Research and Development Authority (BARDA) Contract Valued Up to $26.3 Million for Advanced Development of OrbeShield™ in GI ARS
9/19/2013